FR 
EN 
Solutions d’études en vie réelle
Unlock post-approval insights and ensure regulatory compliance with Cytel’s comprehensive analytics-driven support. We leverage real-world evidence and advanced analytical methods to drive continued success and inform new drug developments beyond market entry.
Maximize Post-Approval Success with Data-Driven Expertise
Secure your chances of post-approval excellence with Cytel’s strategic solutions. Beyond regulatory clearance, we prioritize patient safety and product efficacy through meticulous monitoring and real-world evidence (RWE) analysis. Our tailored services encompass RWE, real-world data (RWD), software solutions, and Études de sécurité post-autorisation (PASS), ensuring compliance, optimizing lifecycle management, and fostering stakeholder trust.
Experience the synergy of regulatory expertise and data-driven insights to navigate the intricacies of post-approval success, maximizing drug value and increasing your commercial viability in the dynamic pharmaceutical landscape.
Real-World Evidence (RWE)
Take advantage of our advanced quantitative techniques to generate robust evidence for regulatory and payer acceptance, support successful product development, and enhance your market access strategies globally.
Real-World Data (RWD)
Unlock valuable insights with Real-World Data (RWD) solutions from Cytel. Harness the power of real-world data to inform critical decisions, drive innovation, and enhance patient outcomes in healthcare.
Logiciel de données de vie réelle
Optimize your RWD selection process with Cytel’s Fit-For-Purpose Data Wizard. Quickly identify high-quality data sources, saving time and resources. Streamline study start-ups by eliminating weeks spent on data landscaping and feasibility assessments.
Études de sécurité post-autorisation (PASS)
Our comprehensive Post-Authorization Safety Studies (PASS) solutions empower you to navigate regulatory requirements, ensure patient safety, and optimize the value of your drug post-approval.
>75
Unique global RWD sources
>50
Dedicated RWE team members
300
Peer-reviewed publications on ECA studies and comparative analyses
>1B
Patient data points
Demandez une séance gratuite de 30 minutes pour votre stratégie
Réservez une séance de stratégie gratuite et sans obligation avec un expert de Cytel pour obtenir des conseils afin d’améliorer les chances de réussite de votre médicament et définir un parcours plus clair vers le marché.
